MOLECULAR BASIS AND USE OF A RADIAL GLIA CELL LINE C6-R
放射状胶质细胞系 C6-R 的分子基础和用途
基本信息
- 批准号:6133912
- 负责人:
- 金额:$ 25.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-02-01 至 2004-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Radial glial cells appear transiently during neural development and play key roles in cell migration and differentiation. However, they have been difficult to study because they are unstable in culture and cell lines with radial glial properties have not been available. We have derived a stable cell line (C6-R) from the rat C6 glioma cell line by transfection with a mutant phosphatase receptor. C6-R has radial morphology and stimulates neuronal migration in culture and in vivo. Although both C6-R and C6 can proliferate rapidly in culture, C6-R is unable to form tumors in rat brain like C6. Since expression of the transfected mutant receptor in many other C6 clones can not account for the phenotypic differences between C6-R and C6, it is likely that the alteration is due to genetic disruption at a single integration site that has been detected in Southern blots of C6-R genomic DNA. We hypothesize that this integration event disrupted genes that either promote glial tumor formation or suppress gliogenesis. The goals of this proposal are to understand the cellular properties of C6-R and the molecular basis of this unique phenotype. In addition, given the ability of C6-R cells to migrate and align along white matter in mature CNS and to support neuronal migration, they will be implanted in the CNS to explore their ability to promote growth of nerves in various situations including following injury. To understand the reduced ability of C6-R to form tumors in vivo, its cellular properties, including proliferation and death, will be compared with the parental C6 cell line. Molecular analysis will be directed to identify the genetic alterations responsible for transformation C6 into C6-R cells and the resulting differences in expression that are responsible for their phenotypic differences. Plasmid rescue and genomic cloning methods will be used to recover DNA from the locus of plasmid insertion. Genes at this locus, and other identified by subtractive suppression hybridization (SSH) using mRNA from C6-R and C6 will be analyzed to determine their roles in gliogenesis and formation of gliomas. These studies will lead to a better understanding of genes that are involved in glial development and in formation of high grade tumors. Studies of the reversion of C6-R to cells that can form tumors in vivo may have implications for understanding how gliomas progress to high grade malignancies. Finally, characterization of radial glial cell lines may yield new methods for promoting nerve growth following injury.
径向神经胶质细胞在神经发育过程中瞬时出现,并在细胞迁移和分化中起关键作用。但是,它们很难研究,因为它们在具有径向神经胶质特性的细胞系中不稳定。我们通过用突变磷酸酶受体转染从大鼠C6胶质瘤细胞系中得出了稳定的细胞系(C6-R)。 C6-R具有径向形态,并刺激培养和体内的神经元迁移。尽管C6-R和C6在培养中均可快速增殖,但C6-R无法像C6这样的大鼠大脑中形成肿瘤。由于在许多其他C6克隆中转染突变受体的表达无法解释C6-R和C6之间的表型差异,因此这种改变很可能是由于单个整合位点的遗传破坏引起的,该位点已在C6-R基因组DNA的Southern印迹中检测到。我们假设这种整合事件破坏了促进神经胶质肿瘤形成或抑制神经胶质发生的基因。该提案的目标是了解C6-R的细胞特性以及该独特表型的分子基础。此外,鉴于C6-R细胞在成熟的中枢神经系统中沿白质迁移和对齐的能力并支持神经元迁移,因此将植入中枢神经系统中的CNS探索它们在各种情况下促进神经生长的能力,包括损伤。为了了解C6-R在体内形成肿瘤的能力降低,将将其细胞特性(包括增殖和死亡)与亲本C6细胞系进行比较。分子分析将被指示以确定导致C6转化为C6-R细胞的遗传改变以及导致其表型差异的表达差异。质粒救援和基因组克隆方法将用于从质粒插入轨迹的基因座中恢复DNA。该基因座的基因以及其他通过C6-R和C6的mRNA通过减法抑制杂交(SSH)鉴定的基因将进行分析,以确定它们在神经胶质瘤的神经胶质发生和形成中的作用。这些研究将使人们对参与神经胶质发育和高级肿瘤形成的基因有更好的了解。 C6-R重新转化为可以在体内形成肿瘤的细胞的研究可能对了解神经胶质瘤如何发展为高级恶性肿瘤有影响。最后,径向神经胶质细胞系的表征可能会产生新的方法来促进损伤后神经生长。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARTIN H GRUMET其他文献
MARTIN H GRUMET的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARTIN H GRUMET', 18)}}的其他基金
Lumbar Puncture Delivery of MSC & Function in Spinal Cord Injury
腰椎穿刺输送 MSC
- 批准号:
7877507 - 财政年份:2010
- 资助金额:
$ 25.49万 - 项目类别:
Lumbar Puncture Delivery of MSC & Function in Spinal Cord Injury
腰椎穿刺输送 MSC
- 批准号:
8015252 - 财政年份:2010
- 资助金额:
$ 25.49万 - 项目类别:
MOLECULAR BASIS AND USE OF A RADIAL GLIA CELL LINE C6-R
放射状胶质细胞系 C6-R 的分子基础和用途
- 批准号:
2738814 - 财政年份:1999
- 资助金额:
$ 25.49万 - 项目类别:
MOLECULAR BASIS AND USE OF A RADIAL GLIA CELL LINE C6-R
放射状胶质细胞系 C6-R 的分子基础和用途
- 批准号:
6499423 - 财政年份:1999
- 资助金额:
$ 25.49万 - 项目类别:
NR/CAM AND FORMATION OF NODE OF RANVIER
NR/CAM 和 RANVIER 节点的形成
- 批准号:
6130146 - 财政年份:1999
- 资助金额:
$ 25.49万 - 项目类别:
PROMOTION OF NERVE REGENERATION BY FRAGMENTS OF L1
L1 片段促进神经再生
- 批准号:
2798611 - 财政年份:1999
- 资助金额:
$ 25.49万 - 项目类别:
MOLECULAR BASIS AND USE OF A RADIAL GLIA CELL LINE C6-R
放射状胶质细胞系 C6-R 的分子基础和用途
- 批准号:
6629306 - 财政年份:1999
- 资助金额:
$ 25.49万 - 项目类别:
NR/CAM AND FORMATION OF NODE OF RANVIER
NR/CAM 和 RANVIER 节点的形成
- 批准号:
6394178 - 财政年份:1999
- 资助金额:
$ 25.49万 - 项目类别:
相似国自然基金
NudC在细胞初级纤毛生长调节中的作用及分子机制研究
- 批准号:31471259
- 批准年份:2014
- 资助金额:80.0 万元
- 项目类别:面上项目
溶血磷脂酸在心梗后心肌重塑中作用及受体调节信号研究
- 批准号:30170374
- 批准年份:2001
- 资助金额:18.0 万元
- 项目类别:面上项目
中枢神经生长调节的细胞和分子基础
- 批准号:39930090
- 批准年份:1999
- 资助金额:100.0 万元
- 项目类别:重点项目
相似海外基金
Epithelial-mesenchymal crosstalk in intestinal polyp formation
肠息肉形成中的上皮-间质串扰
- 批准号:
10604626 - 财政年份:2023
- 资助金额:
$ 25.49万 - 项目类别:
Project 1: Targeting HSPA Proteins in Advanced and Recurrent Endometrial Cancer Therapy
项目 1:针对晚期和复发性子宫内膜癌治疗中的 HSPA 蛋白
- 批准号:
10711636 - 财政年份:2023
- 资助金额:
$ 25.49万 - 项目类别:
Characterization of Altered Fatty Acid Trafficking in Triple-Negative Breast Cancer
三阴性乳腺癌中脂肪酸运输改变的特征
- 批准号:
10734556 - 财政年份:2023
- 资助金额:
$ 25.49万 - 项目类别:
Determining the mechanism for YAP1 activation by HPV E7 in oropharyngeal carcinoma
确定口咽癌中 HPV E7 激活 YAP1 的机制
- 批准号:
10606110 - 财政年份:2023
- 资助金额:
$ 25.49万 - 项目类别:
Developing novel therapy to improve outcomes in MCL
开发新疗法以改善 MCL 的预后
- 批准号:
10717196 - 财政年份:2023
- 资助金额:
$ 25.49万 - 项目类别: